ImmunoForge, a spin-out from Gachon University, is a drug development company focusing on sarcopenia and cancer. Based on its unique patent for the use of GLP-1 analogues for sarcopenia, ImmunoForge are targeting Duchenne muscular dystrophy, ALS, senile sarcopenia, polymyositis and cancer cachexia. Also, it focuses on genomically defined rare cancers, such as chronic myelogenous leukemia with BCR-ABL1 T315I mutation, which is resistant to BCR-ABL1 inhibitors.
View Top Employees from ImmunoForge| Website | http://www.immunoforge.com |
| Revenue | $5 million |
| Employees | 4 (4 on RocketReach) |
| Founded | 2017 |
| Phone | +82 70-7721-0755 |
| Industry | Drug Stores & Pharmacies, Health Care, Drug Discovery, Retail, Therapeutics, Biotechnology |
| SIC | SIC Code 51 Companies, SIC Code 512 Companies |
| NAICS | NAICS Code 424 Companies, NAICS Code 4242 Companies, NAICS Code 42 Companies, NAICS Code 42421 Companies |
Looking for a particular ImmunoForge employee's phone or email?
ImmunoForge Questions
The ImmunoForge annual revenue was $5 million in 2024.
4 people are employed at ImmunoForge.
ImmunoForge is based in Seoul, Seoul.
The NAICS codes for ImmunoForge are [424, 4242, 42, 42421].
The SIC codes for ImmunoForge are [51, 512].
Top ImmunoForge Employees
-
33
-
2
-
1
